Paul Balderes, based in New York, NY, US, is currently a Senior Director Biologics Discovery at TRI-TDI at Tri-Institutional Therapeutics Discovery Institute, Inc., bringing experience from previous roles at TRI-TDI, Eli Lilly and Company and ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company. With a robust skill set that includes Drug Discovery, Monoclonal Antibodies, Assay Development, Protein Chemistry, Antibodies and more, Paul Balderes contributes valuable insights to the industry. Paul Balderes has 2 emails on RocketReach.